|
 |
|
|
| |
|
| |
 |
Formulation
Plant-I : The Plant approved as per FDCA – INDIA Schedule M, cGMP, Tablet, Capsule, ORS and Betalactum with R & D and Pilot plant for trial of new molecules. Tablet, Capsule & ORAl powder, Beta lactum Tablet, the facility incorporater with individual air handling systems comprising air pressure differentials & appropriate airfilters as per WHO cGMP guide line.
Extreme care is observed while designing the production facility to prevent any kind of cross-contamination. |
|
|
| Manufacturing Capacity |
| Products |
Monthly Capacity (Based On Single
Shift) |
| 1. |
Tablet |
100 Million |
| 2. |
Capsules |
50 Million |
| 3. |
Oral Powder |
10 Million |
|
 |
|
| |
| |
|
|
|
|
|
| |
|
|